Representatives from the Shanghai Cell Therapy Group and Stanford Medicine's Radiation Oncology Center pose for a group photo after signing a cooperation deal on Jan 18. [Photo/jiading.gov.cn] |
The Shanghai Cell Therapy Group is China's first conglomerate focusing on a complete immune cell industrial chain. Its businesses cover the R&D, production and clinical application of cell therapy, cell storage, gene testing, medical cosmetology and healthcare.
The company has multiple self-developed patents and technologies. It has also launched a medical program, aimed at giving effective and affordable treatment to 60 percent of Chinese cancer patients in the next decade.
The Radiation Oncology Center at Stanford Medicine is a world-renowned research center founded by Henry Kaplan, who developed the first high-energy linear accelerator for therapeutic use in the 1950s.
The center aims to bring the most advanced care to the patients by being at the cutting edge of research and technology. One recent example is that it performed the first stereotactic body radiotherapy (SBRT) and stereotactic ablative radiotherapy (SABR) treatment in the world using the Truebeam linear accelerator.